Rani Therapeutics Holdings, Inc. (RANI)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Rani Therapeutics Holdings, Inc. (RANI)
Company Performance

Current Price

as of Oct 18, 2024

$2.68

P/E Ratio

N/A

Market Cap

$86.54M

Description

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Metrics

Overview

  • HQSan Jose, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerRANI
  • Price$2.68+1.90%

Trading Information

  • Market Cap$86.54M
  • Float64.26%
  • Average Daily Volume (1m)4,451,489
  • Average Daily Volume (3m)1,428,021
  • EPS-$1.18

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$6.81M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$12.27M
  • EV$106.59M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B25.04
Documents
SEC Filings
8-K (2024-10-16)
8-K (2024-09-11)
8-K (2024-08-06)
8-K (2024-07-23)
8-K (2024-07-12)
8-K (2024-06-24)
8-K (2024-05-30)
8-K (2024-05-06)
8-K (2024-03-20)
8-K (2024-02-05)
8-K (2023-12-19)
8-K (2023-12-14)
8-K (2023-11-08)
8-K (2023-11-01)
8-K (2023-10-25)
8-K (2023-09-07)
8-K (2023-08-11)
8-K (2023-06-05)
8-K (2023-05-30)
8-K (2023-05-10)
8-K (2023-04-05)
8-K (2023-03-22)
8-K (2023-01-09)
8-K (2023-01-05)
10-Q (2024-08-06)
10-Q (2024-05-06)
10-Q (2023-11-08)
10-Q (2023-08-11)
10-Q (2023-05-10)
10-K (2024-03-20)
10-K (2023-03-22)
Earnings Calls
Earnings Report 2023Q4
Earnings Report (2023-03-22)
Factset
Factset Business Description
Factset Street Account
Rani Therapeutics reports Q3 EPS ($0.36) vs FactSet ($0.43) [8 est, ($0.84)-(0.30)] ($1.98, 0.00) (2023-11-08T21:42:40Z)
Rani Therapeutics announces strategic program prioritization and workforce reduction; reports preliminary Q3 results ($1.91, 0.00) (2023-11-01T21:02:33Z)
Rani Therapeutics announces RaniPill preclinical data ($2.00, 0.00) (2023-10-25T12:01:51Z)